within Pharmacolibrary.Drugs.C_CardiovascularSystem.C01D_VasodilatorsUsedInCardiacDiseases.C01DA08_IsosorbideDinitrate;
model IsosorbideDinitrate 
   extends Pharmacolibrary.Drugs.ATC.C.C01DA08;

  annotation(Documentation(
    info ="<html><body><p>Isosorbide dinitrate is an organic nitrate used primarily as a vasodilator to prevent and treat angina pectoris due to coronary artery disease. It acts by relaxing smooth muscle and dilating blood vessels, thus decreasing cardiac workload and oxygen demand. The drug is approved and in clinical use for treatment of angina and sometimes heart failure.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects (mixed sex).</p><h4>References</h4><ol><li><p>Schaumann, W (1989). Pharmacokinetics of isosorbide dinitrate and isosorbide-5-mononitrate. <i>International journal of clinical pharmacology, therapy, and toxicology</i> 27(9) 445–453. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2681004/&quot;>https://pubmed.ncbi.nlm.nih.gov/2681004</a></p></li><li><p>Platzer, R, et al., &amp; Galeazzi, RL (1982). Pharmacokinetics of intravenous isosorbide-dinitrate. <i>Journal of pharmacokinetics and biopharmaceutics</i> 10(6) 575–586. DOI:<a href=&quot;https://doi.org/10.1007/BF01062541&quot;>10.1007/BF01062541</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7182455/&quot;>https://pubmed.ncbi.nlm.nih.gov/7182455</a></p></li><li><p>Chasseaud, LF (1987). Isosorbide 5-mononitrate pharmacokinetics. <i>Cardiology</i> 74 Suppl 1 6–11. DOI:<a href=&quot;https://doi.org/10.1159/000174255&quot;>10.1159/000174255</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3300979/&quot;>https://pubmed.ncbi.nlm.nih.gov/3300979</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end IsosorbideDinitrate;
